专注于心力衰竭中的微血管功能,并保留了喷射分数.
Ornela Velollari1,2, Karl-Philipp Rommel1,2, Karl-Patrik Kresoja1,2
1Department of Cardiology, Cardiology I, University Medical Center Mainz, Langenbeckstrasse 1, 55131, Mainz, Germany.
Heart failure reviews
|January 13, 2025
概括
在全球范围内,心力衰竭与保存的喷射分数 (HFpEF) 正在上升. 冠状动脉微血管功能障碍 (CMD) 显著影响HFpEF,需要针对性治疗以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 心血管研究研究心血管研究
- 翻译医学是一种翻译医学.
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭是一个日益严重的全球健康问题,占所有心力衰竭病例的一半.
- 病理生理学异质性和对HFpEF机制的有限理解阻碍了有效的治疗开发.
- 冠状动脉微血管功能障碍 (CMD) 越来越多地与HFpEF有关,尽管其确切的因果作用尚不清楚.
研究的目的:
- 本综述审查了HFpEF中CMD的流行率,预后意义和治疗目标.
- 它旨在澄清CMD和HFpEF之间的复杂关系.
- 该审查旨在确定HFpEF潜在的新治疗策略.
主要方法:
- 对HFpEF和CMD现有研究的文献综述.
- 分析CMD和HFpEF之间拟议的病理生理联系.
- 评估当前和新兴的治疗干预措施.
主要成果:
- 冠状动脉疾病可能通过冠状动脉血流受损,心肌缺血和不良心脏重塑导致HFpEF.
- 与HFpEF相关的心脏压力可以通过增加冠状动脉抵抗来加剧CMD.
- 代谢异常可能是CMD和HFpEF的基础.
结论:
- 目前的HFpEF治疗方法的疗效有限,这强调了针对性治疗的必要性.
- 冠状动脉缩器是一种潜在的治疗装置,用于改善HFpEF中的心肌输液.
- 进一步的研究至关重要,以阐明CMD-HFpEF的联系,并开发表型特定的治疗方法.
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:22Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381